文献速递脑血管病外科神经重症

神经血管合并症指数在回顾性数据库分析中的验证

Validation of a neurovascular comorbidities index for retrospective database analysis.
PubMed 文献 · J Neurosurg · 2018-01-26

研究利用2002—2012年全国住院患者样本数据库,验证既往建立的神经血管合并症指数(NCI)在动静脉畸形、破裂颅内动脉瘤、颈动脉狭窄术后患者中预测结局的准确性,并与Charlson合并症指数(CCI)和Elixhauser合并症指数(ECI)比较。结果显示,在12项指标中有11项NCI模型显著更高效,作者认为回顾性结局分析应使用NCI替代CCI或ECI。

要点

  • 在动静脉畸形患者中,NCI预测不良结局、住院时间和总费用优于CCI和ECI,预测死亡与CCI相当。
  • 在破裂颅内动脉瘤患者中,NCI预测死亡、不良结局、住院时间和总费用均优于ECI和CCI。
  • 在颈动脉狭窄患者中,NCI预测住院时间优于ECI和CCI,但预测不良结局劣于CCI。

核心结论

  • NCI通过提供更合适、更高效的死亡、结局、住院时间和费用风险分层,优于CCI和ECI。
  • 作者认为,回顾性患者结局分析应使用NCI而非CCI或ECI。

研究设计与样本

  • 研究查询2002—2012年全国(全美)住院患者样本数据库,比较既往已验证的NCI与CCI、ECI对接受手术干预的动静脉畸形、破裂颅内动脉瘤、颈动脉狭窄或硬脑膜动静脉瘘患者结局预测的准确性。

主要发现

  • 动静脉畸形患者中,NCI预测不良结局、住院时间和总费用优于CCI和ECI,预测死亡与CCI相当。
  • 破裂颅内动脉瘤患者中,NCI预测死亡、不良结局、住院时间和总费用优于ECI和CCI。
  • 颈动脉狭窄患者中,NCI预测住院时间优于ECI和CCI,预测死亡和总费用与ECI相当,预测不良结局劣于CCI(所有比较p < 0.002)。
  • 接受手术干预的硬脑膜动静脉瘘患者数量不足,无法分析(n < 10),因此被排除出研究。
  • 在12项指标中有11项,NCI是显著更高效的模型。

临床怎么用

  • 作者认为,回顾性患者结局分析应使用NCI而非CCI或ECI进行风险分层。

局限性

  • 接受手术干预的硬脑膜动静脉瘘患者数量不足,无法分析(n < 10),因此被排除出研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Comorbidities have a significant effect on patient outcomes. Accounting for this effect is especially important in retrospective reviews of large databases; overpowered studies are at risk for finding significant results because of inaccurate patient risk stratification. The authors previously created a neurovascular comorbidities index (NCI) for patients with an unruptured intracranial aneurysm and found that the model's ability to predict patient outcomes was statistically significantly improved over that of the routinely used Charlson Comorbidity Index (CCI) and Elixhauser Comorbidity Index (ECI). In this study, the authors aimed to validate use of the NCI over that of the CCI and ECI for risk stratification of patients with other neurovascular diseases. METHODS: The authors queried the National (Nationwide) Inpatient Sample database for the years 2002-2012 to compare the accuracy of the previously validated NCI with that of the CCI and ECI with respect to predicting outcomes for patients who had an arteriovenous malformation, a ruptured intracranial aneurysm, carotid artery stenosis, or dural arteriovenous fistula and who underwent surgical intervention. RESULTS: For patients with an arteriovenous malformation, the NCI outperformed the CCI and ECI in predicting poor outcome, hospital length of stay (LOS), and total cost but was equivalent to the CCI in predicting death. For patients with a ruptured intracranial aneurysm, the NCI outperformed the ECI and CCI in predicting death, poor outcome, LOS, and total cost. For patients with carotid artery stenosis, the NCI outperformed the ECI and CCI in predicting LOS, but it was equivalent to the ECI in predicting death and total cost and inferior to the CCI in predicting poor outcome (p < 0.002 for all). An insufficient number of patients with dural arteriovenous fistula who underwent surgical intervention were available for analysis (n < 10), and they therefore were excluded from study. For 11 of 12 metrics, the NCI was the significantly more efficient model. CONCLUSIONS: The NCI outperforms the CCI and ECI by providing more appropriate and efficient risk stratification of patients regarding death, outcome, LOS, and cost. Given this finding, the NCI should be used for retrospective reviews of patient outcomes instead of the CCI or ECI.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Newman WC, Kubilis PS, Hoh BL, et al. Validation of a neurovascular comorbidities index for retrospective database analysis. J Neurosurg. 2018. PMID: 29372882. doi:10.3171/2017.8.JNS171413

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。